查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球腹股溝疝氣器材市場 -2023-2030
市場調查報告書
商品編碼
1374795

全球腹股溝疝氣器材市場 -2023-2030

Global Inguinal Hernia Devices Market -2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

腹股溝疝氣裝置是用來促進疝氣周圍受傷組織癒合的醫療裝置。這些設備用於腹股溝疝氣修補術，這是一種將疝氣隆起壓回原位並加強腹壁薄弱部位的外科手術。腹股溝疝氣裝置通常由網狀材料組成，並縫合、釘合或粘合在疝氣周圍的區域。

網狀物中的孔允許組織生長到裝置中，從而減少疝氣復發或復發的機會。除了網狀裝置外，在腹股溝疝氣修補手術中還可以使用縫線（縫線），有時還可以使用網狀裝置。

修復疝氣的手術可以是開腹手術或腹腔鏡手術，外科醫師會確定哪種麻醉方式最適合病人。總的來說，腹股溝疝氣裝置是腹股溝疝氣手術治療的關鍵組成部分，它們可以幫助支撐受損組織並防止疝氣復發。

市場動態：促進因素與限制因素

腹股溝疝氣修補術數量不斷增加

腹股溝疝氣修補術數量的增加是腹股溝疝氣器材市場的主要驅動力。例如，根據美國外科醫師學會2023 年報告，光是在美國每年就進行100 萬例腹股溝疝氣修補手術，全球估計每年進行超過2,000 萬例此類手術，疝氣修補術已成為最常進行的普通外科手術之一全球。

此外，該報告強調腹股溝疝氣的發生率不斷增加，顯示對疝氣修復方案的巨大需求。需求激增表明醫療設備製造商需要開發創新產品，例如腹部3D (3D) 成像，使醫生能夠透過小切口進行手術，而不是傳統開放性手術中的大切口，從而減少組織損傷、減少疼痛并加快患者術後恢復，從而滿足對成功的疝氣修復手術日益成長的需求。

市場動態：克制

與疝氣設備相關的高成本以及監管機構的挑戰可能是一個潛在的障礙，並對預測期內的全球腹股溝疝氣設備市場產生重大影響。這些設備的高成本可能會限制欠已開發地區獲得治療的機會，給醫療機構帶來壓力，並影響患者選擇手術的決策。

嚴格的法規核准流程和合規成本可能會對希望進入市場或開發產品的公司造成障礙。持續疼痛、感染、疝氣復發、沾黏、腸阻塞、補片相關問題等併發症可能會導致不滿意，並需要額外的醫療介入。這不會影響醫療費用，但也會阻止一些人接受疝氣修補手術。對於行業利益相關者來說，克服這些挑戰對於促進市場成長至關重要。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按類型分類
  • 按產品分類
  • 按年齡層別分類
  • 手術程序片段
  • 最終使用者的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 腹股溝疝氣修補術數量不斷增加
    • 限制
      • 疝氣裝置的高成本以及監管機構帶來的挑戰
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按類型

  • 腹股溝斜疝
  • 腹股溝直疝
  • 雙側腹股溝疝氣
  • 股疝

第 8 章：依產品

  • 疝氣網片
  • 疝氣固定裝置
  • 疝氣修補耗材

第 9 章：按年齡層

  • 兒科
  • 成人

第 10 章：透過手術程序

  • 開放性手術
  • 腹腔鏡手術
  • 機器人輔助疝氣修復
  • 非網格過程

第 11 章：最終用戶

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

第 12 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第13章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 14 章：公司簡介

  • Olympus Corporation
    • 公司簡介
    • 產品類型組合和描述
    • 財務概覽
    • 主要進展
  • Johnson & Johnson
  • Sinolinks Medical Innovation, Inc.
  • Beijing Biosis Healing Biological Technology Co.,Ltd
  • Betatech Medical
  • Medtronic
  • WL Gore & Associates, Inc.
  • Dynamesh Inc.
  • Cousin Biotech
  • Cook Medical

第 15 章：附錄

簡介目錄
Product Code: MD7311

Overview

Inguinal hernia devices are medical devices that are used to promote the healing of injured tissue around hernias. These devices are used in inguinal hernia repair, a surgical procedure that presses a hernia bulge back into position and reinforces the abdominal wall weakness. Inguinal hernia devices usually consist of mesh and are stitched, stapled, or glued across the area surrounding the hernia.

Pores in the mesh allow tissue to grow into the device, which reduces the chance of a hernia recurring or relapsing. In addition to mesh devices, sutures (stitches) and sometimes mesh may be utilized during inguinal hernia repair surgery.

The surgery to repair the hernia can be open or laparoscopic, and the surgeon will determine which type of anesthesia is best for the patient. Overall, inguinal hernia devices are a key component of the surgical treatment of inguinal hernias, and they can help to support damaged tissue and prevent the hernia from returning.

Market Dynamics: Drivers and Restraints

The increasing number of inguinal hernia repairs

The rising number of inguinal hernia repairs is a major driver of the inguinal hernia device market. For instance, according to the American College of Surgeons 2023 report, 1 million inguinal hernia repairs are performed annually in the U.S. alone and a global estimate exceeding 20 million such surgeries each year, hernia repair has become one of the most often performed general surgical procedures globally.

Furthermore, this report emphasizes the increasing occurrence of inguinal hernias, indicating a huge demand for hernia repair options. This spike in demand indicates the need for medical device manufacturers to develop innovative products such as three-dimensional (3D) imaging of the abdomen allowed doctors to perform surgery through small incisions rather than the huge incisions linked with traditional open surgery, leading to less tissue damage, less pain, and faster postoperative recovery for patients and thereby fulfilling the rising need for successful hernia repair procedures.

Market Dynamics: Restraint

The high cost associated with hernia devices and the challenges posed by regulatory bodies can be a potential barrier and have a significant impact on the global inguinal hernia device market over the forecast period. The high cost of these devices may limit access to treatment in under developed regions and put strain on healthcare facility and influence patients decision making when it comes to opting for surgery.

The strict regulatory approval processes and compliance costs can create obstacles for companies looking to enter the market or develop products. Complications such as persistent pain, infections, hernia recurrence, adhesions, bowel obstructions, mesh-related issuesand others can lead to dissatisfaction and necessitate additional medical interventions. This not affects healthcare costs but also discourages some individuals from undergoing hernia repair surgery. Overcoming these challenges is crucial for industry stakeholders in order to foster growth, in the market.

Segment Analysis

The global inguinal hernia device market is segmented based on type, product, age group, surgical procedure, end user and region.

The hernia mesh segment accounted for approximately 44.2 % of the market share

The hernia mesh segment accounted for 44.2% and it is expected to be dominated during the forecast period. The segment holds a position, in the market due to its usage and effectiveness in inguinal hernia repair procedures. These meshes offer support to weakened abdominal walls reducing the chances of hernia recurrence. They are available in materials and designs catering to the needs of patients. Additionally, rise of minimal invasive procedures has led to popularity due increasing number of surgeries has led to a higher demand, for hernia meshes as they work well with these procedures.

The increasing funding for the development of advanced mesh will create a positive impact on the market. For instance, in August 2022, Deep Blue Medical Advances, a Durham company previously funded with more than $400,000 in North Carolina Biotechnology Center loans, has raised more than $7 million in venture capital to facilitate development with the commercialization of its T-Line Hernia Mesh product. This innovative device intends to eliminate a common source of failure in conventional mesh fixation, reinforce anchors, and improve hernia repair procedures.

Furthermore, in February 2022, Dolphin Mesh, manufactured in India by Futura Surgicare Pvt Ltd, launched a premium surgical mesh brand built for "tension-free" and laparoscopic hernia repairs. These meshes serve as crucial devices in surgeries that strengthens weakened areas, enable tissue ingrowth, and may be modified to meet individual surgical demands. Thus, owing to the above factors the segment is expected to dominate over the forecast period.

Geographical Analysis

North America accounted for approximately 37.4% of the market share in 2022

North America is estimated to hold about 37.4% of the total market share throughout the forecast period, owing to the increasing number of investment, increasing prevalence of hernia, product approvals and FDA clearance, collaboration with the key players, and others that will drive this region further during the forecast period.

For instance, in October 2022, Medtronic plc, a prominent global healthcare technology business, received approvals for its Hugo robotic-assisted surgery (RAS) system, expanding its market reach and indications globally. Particulary, Health Canada has received a license for general laparoscopic surgery use. These approvals bring up new options for minimally invasive surgery in Europe, North America, and Asia, making the benefits more accessible globally. These treatments range from simple to sophisticated and include cholecystectomy, inguinal hernia repair, gastric bypass, and lower anterior resection.

Furthermore, in June 2023, Advanced Medical Solutions Group plc, a world leader in tissue-healing technologies, received the U.S. FDA approval for the Pre-Market Approval (PMA) of LiquiBandFix8 for use in hernia surgery. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. To secure mesh to tissue within the body during hernia surgery, LiquiBandFix8 uses droplets of cyanoacrylate adhesive rather than sharp tacks. Thus, owing to the above factors the region is expected to dominate over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has majorly impacted the market, as it has resulted in a significant decrease in the amount of elective hernia repairs, particularly incisional hernia surgery. For instance, according to British Journal of Surgery 2022 article, inguinal hernia is a common surgical disease in children, with a 6% to 16% frequency in preterm and low-birthweight infants. The COVID-19 pandemic impacted hospital services, but it also presented a unique opportunity to collect clinical outcomes for children with inguinal hernia who would face delays in operative therapy, including the chance of spontaneous resolution while awaiting operative repair.

During the COVID-19 pandemic, twenty-five UK pediatric surgical centers took part in observational research evaluating the therapy of inguinal hernia in infants under 6 months of age. The study discovered a substantial decrease in the frequency of inguinal hernia repairs performed during the pandemic compared to the same period in the previous year.

Competitive Landscape

The major global players in the inguinal hernia devices market include: B Braun Melsungen AG, Johnson & Johnson, Sinolinks Medical Innovation, Inc., Beijing Biosis Healing Biological Technology Co.,Ltd, Betatech Medical, Medtronic, W. L. Gore & Associates, Inc., Dynamesh Inc., Cousin Biotech, Cook Medical and among others.

Why Purchase the Report?

  • To visualize the global inguinal hernia devices market segmentation-based on type, product, age group, surgical procedure, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of inguinal hernia devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global inguinal hernia devices market report would provide approximately 79 tables, 79 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by Surgical Procedure
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. The increasing number of inguinal hernia repairs
    • 4.1.2. Restraints
      • 4.1.2.1. The high cost associated with hernia devices and the challenges posed by regulatory bodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Indirect Inguinal Hernia*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Direct Inguinal Hernia
  • 7.4. Bilateral Inguinal Hernia
  • 7.5. Femoral Hernia

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Hernia Meshes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hernia Fixation Devices
  • 8.4. Hernia Repair Consumables

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Pediatric*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Adult

10. By Surgical Procedure

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 10.1.2. Market Attractiveness Index, By Surgical Procedure
  • 10.2. Open Surgery*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Laparoscopic Surgery
  • 10.4. Robotic-assisted Hernia Repair
  • 10.5. Non-mesh Procedures

11. By End-users

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 11.1.2. Market Attractiveness Index, By End-users
  • 11.2. Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Ambulatory Surgical Centers
  • 11.4. Specialty Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. UK
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Olympus Corporation*
    • 14.1.1. Company Overview
    • 14.1.2. Product Type Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Johnson & Johnson
  • 14.3. Sinolinks Medical Innovation, Inc.
  • 14.4. Beijing Biosis Healing Biological Technology Co.,Ltd
  • 14.5. Betatech Medical
  • 14.6. Medtronic
  • 14.7. W. L. Gore & Associates, Inc.
  • 14.8. Dynamesh Inc.
  • 14.9. Cousin Biotech
  • 14.10. Cook Medical

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us